Explore company news, scientific progress, and thoughts from our team.
The biggest challenge Dr. Mat Legut faced as a founder was balancing his roles as scientist and entrepreneur. Learn why life sciences startups like OverT Bio choose J.P. Morgan to support them at all stages of growth.
Nona Biosciences, a global biotechnology company providing a total solution from “Idea to IND” (I to ITM), today announced a strategic collaboration with OverT Bio, a New York-based biotechnology company. The collaboration will focus on developing next-generat
A new biotech is coming out of stealth with $16 million to develop cell therapies for solid cancers.
OverT Bio, an NYC-based cell therapy company, today announced that it has been awarded a $120,000 G-Rex Grant from ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM.
Life-sciences companies have physical requirements that the majority of New York City buildings can’t accommodate. However, as the city's former printing district, Hudson Square can.
The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. Now, scientists at the New York Ge
Contact
